<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(9)</volume><submitter>Zhu K</submitter><funding>National Natural Science Foundation of China</funding><pubmed_abstract>Viruses often manipulate ubiquitination pathways to facilitate their replication and pathogenesis. CUL2&lt;sup>ZYG11B&lt;/sup> known as the substrate receptor of cullin-2 RING E3 ligase, is bound by SARS-CoV-2 ORF10 to increase its E3 ligase activity, leading to degradation of IFT46, a protein component of the intraflagellar transport (IFT) complex B. This results in dysfunctional cilia, which explains certain symptoms that are specific to COVID-19. However, the precise molecular mechanism of how ORF10 recognizes CUL2&lt;sup>ZYG11B&lt;/sup> remains unknown. Here, we determined the crystal structure of CUL2&lt;sup>ZYG11B&lt;/sup> complexed with the N-terminal extension (NTE) of SARS-CoV-2 ORF10 (2.9 Å). The structure reveals that the ORF10 N-terminal heptapeptide (NTH) mimics the Gly/N-degron to bind CUL2&lt;su</pubmed_abstract><journal>Acta pharmaceutica Sinica. B</journal><pagination>4164-4173</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11413682</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>SARS-CoV-2 ORF10 hijacking ubiquitination machinery reveals potential unique drug targeting sites.</pubmed_title><pmcid>PMC11413682</pmcid><pubmed_authors>Song L</pubmed_authors><pubmed_authors>Yuan S</pubmed_authors><pubmed_authors>Luo Z</pubmed_authors><pubmed_authors>Zhu K</pubmed_authors><pubmed_authors>Wang T</pubmed_authors><pubmed_authors>Mi W</pubmed_authors><pubmed_authors>Gao X</pubmed_authors><pubmed_authors>Cui S</pubmed_authors><pubmed_authors>Hua L</pubmed_authors><pubmed_authors>Qin B</pubmed_authors><pubmed_authors>Wang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>SARS-CoV-2 ORF10 hijacking ubiquitination machinery reveals potential unique drug targeting sites.</name><description>Viruses often manipulate ubiquitination pathways to facilitate their replication and pathogenesis. CUL2&lt;sup>ZYG11B&lt;/sup> known as the substrate receptor of cullin-2 RING E3 ligase, is bound by SARS-CoV-2 ORF10 to increase its E3 ligase activity, leading to degradation of IFT46, a protein component of the intraflagellar transport (IFT) complex B. This results in dysfunctional cilia, which explains certain symptoms that are specific to COVID-19. However, the precise molecular mechanism of how ORF10 recognizes CUL2&lt;sup>ZYG11B&lt;/sup> remains unknown. Here, we determined the crystal structure of CUL2&lt;sup>ZYG11B&lt;/sup> complexed with the N-terminal extension (NTE) of SARS-CoV-2 ORF10 (2.9 Å). The structure reveals that the ORF10 N-terminal heptapeptide (NTH) mimics the Gly/N-degron to bind CUL2&lt;su</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2026-06-01T19:28:58.464Z</modification><creation>2025-04-04T02:19:21.195Z</creation></dates><accession>S-EPMC11413682</accession><cross_references><pubmed>39309499</pubmed><doi>10.1016/j.apsb.2024.05.018</doi></cross_references></HashMap>